Rockwell Medical (RMTI) Tops Q2 EPS by 4c ; offers guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 --0%
Revenue Growth %: +14.9%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.33 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.23 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
